The authors used a genuinely novel in vivo design: ultrasound-guided intrafollicular injection of the MEK inhibitor PD0325901 into the dominant follicle of synchronized beef cows 30 min before GnRH. At 50 Β΅M, 4 of 5 cows failed to ovulate, and day-5 plasma progesterone was lower at 10 and 50 Β΅M (P < 0.05) . Phospho-ERK1/2 reduction in granulosa cells at 6 h confirmed target engagement.
RNA-seq (DESeq2, |log2FC|>1, q<0.01) found 2121 LH-induced DEGs (1426 up, 695 down) between Vehicle+GnRH and Vehicle, and 285 ERK1/2-dependent DEGs (only 33 up; 252 down) between PD0325901+GnRH and Vehicle+GnRH. Critically, 210 DEGs overlapped, with 196 being LH-induced but ERK1/2-dependent β a coherent directional signature . RT-qPCR validated EGR1, ADAMTS1, TNFAIP6, STAT3, and TIMP1 suppression; inflammatory/TNF signaling pathways dominated enrichment, consistent with ovulation as an inflammatory-like process.
Counter to the mouse paradigm, STAR mRNA was not reduced, and STAR protein was higher in both granulosa and theca cells of inhibited follicles, with follicular progesterone unchanged (~696 vs ~828 ng/mL, P > 0.05) . SLC16A1 (BHBA transporter) was the most notable inhibitor-induced gene in both cell types, prompting a plausible but untested hypothesis about ketone-body-driven luteinization. This species discordance is a genuine contribution but remains an observation without a mechanism β the authors appropriately flag it as inference.
What would change the conclusion: genetic granulosa-specific ERK1/2 disruption in cattle, multi-timepoint transcriptomics, or a larger dose-response showing no ovulation effect would falsify the central claim. The authors correctly note the STAR finding contradicts mouse data rather than forcing it into the mouse narrative β commendable restraint.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.